Drug & supplement interaction

Chirata + Obinutuzumab

Obinutuzumab brand name: Gazyva.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Chirata and Obinutuzumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Obinutuzumab states a food rule worth keeping to.

Know someone taking this? Share
Interaction report

Chirata and Obinutuzumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Obinutuzumab and Chirata in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Chirata safety at a glance

Chirata overall Use caution Generally used in small amounts in traditional medicine, but human safety data are limited.
Pregnancy Avoid Not enough safety data; avoid use during pregnancy.
Breastfeeding Avoid Not enough safety data; avoid use while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Obinutuzumab and Chirata? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Keep it in perspective

Chirata Does Interact With Other Medications

Chirata has 86 moderate known drug interactions in our database — Obinutuzumab isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Chirata

Covers the 2,830 medications we’ve checked against Chirata. Pick one to open its full report.

What to actually watch for

What Obinutuzumab’s Own FDA Label Lists

This is not an interaction — none of it involves Chirata. These are the most notable effects listed in the ADVERSE REACTIONS section of Obinutuzumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • High potassium Worth acting on
  • Low sodium Worth acting on
  • Low potassium Worth acting on
  • A low platelet count Worth acting on
  • Kidney problems Worth acting on
  • Anemia Worth acting on
  • A low white blood cell count Worth acting on
  • Liver problems Worth acting on
  • A higher chance of infection Worth acting on
  • An allergic reaction Worth acting on

Showing the 10 most notable of 17 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Obinutuzumab. Read the label on DailyMed › Chirata’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Chirata side to compare — that is a limit of the record, not a statement that Chirata has no side effects.

How to take them

Some Obinutuzumab Products Have a Food Rule — Chirata Should Not Break It

At least one FDA label for a product containing Obinutuzumab says to take it on an empty stomach. Most supplements — Chirata included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Obinutuzumab on its own and move Chirata to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Obinutuzumab products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

650–1,000 mg acetaminophen At least 30 minutes before GAZYVA infusion.

From the Dosage and Administration section of the FDA label we read for Obinutuzumab — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

Overlapping uses

What Obinutuzumab Is Prescribed For, and What Chirata Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Obinutuzumab is a prescription medicine with approved uses on its FDA label. Chirata is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Obinutuzumab is prescribed for: Gazyva is used to treat three conditions. For chronic lymphocytic leukemia (CLL), it is given in combination with chlorambucil in patients who have not been treated before. For follicular lymphoma (FL), it is used either with bendamustine (for patients whose disease came back or stopped responding to a rituximab-based regimen) or with chemotherapy (for previously untreated advanced disease) — in both cases followed by Gazyva alone as maintenance therapy. Gazyva is also approved for active lupus nephritis — a type of kidney inflammation caused by lupus — in adults who are already receiving standard therapy for the condition.

Chirata has been studied for:

  • Cancer studied, not established Chirata has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Chirata for cancer

    Although there has been interest in using oral chirata for cancer, there is insufficient reliable information about the clinical effects of chirata for this purpose.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Obinutuzumab on your own; if you are taking Chirata for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

One more smart check

Taking Chirata as Part of a Dietary Supplement Product? Check It for Interactions

We hold 26 real supplement products containing Chirata, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Chirata. Even though Chirata itself has no known interaction with Obinutuzumab, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Chirata and Obinutuzumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Chirata
Steady interest

#802 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Obinutuzumab
Steady interest

#1,860 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Chirata reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Chirata and Obinutuzumab records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Chirata

What is Chirata?

  • Digestive upset and loss of appetite
  • Fever
  • Blood sugar support
  • Liver health support
  • Skin conditions
  • General 'blood purifier' or tonic

Chirata is a very bitter herb used in traditional Ayurvedic and South Asian medicine, mainly for digestion, fever, and as a general tonic. Human evidence for its benefits is limited, so it should not replace proven treatments, and you should talk to a pharmacist or doctor before using it.

Swertia chirayita · Gentianaceae · Whole plant, especially the dried stems and leaves · Powder, capsules, tablets, water infusion (cold or hot), liquid extract, and traditional herbal blends

An interaction check asks whether these two react with each other — it does not ask whether Chirata is a good idea for someone in your situation. Here is what our Chirata record says about it on its own.

Chirata: dosing

There is no well-established, standardized dose for chirata. The right amount can depend on the form (powder, capsule, or infusion) and the strength of the product.The safest approach is to follow the directions on the product label and not exceed the recommended amount.

From our Chirata monograph — the full record covers uses, side effects and every documented interaction.

Read the full Chirata monograph & all interactions
Medication

About Obinutuzumab Injection

What Is Obinutuzumab Injection Used For?

Brand name: Gazyva

Gazyva is used to treat three conditions. For chronic lymphocytic leukemia (CLL), it is given in combination with chlorambucil in patients who have not been treated before. For follicular lymphoma (FL), it is used either with bendamustine (for patients whose disease came back or stopped responding to a rituximab-based regimen) or with chemotherapy (for previously untreated advanced disease) — in both cases followed by Gazyva alone as maintenance therapy.

Gazyva is also approved for active lupus nephritis — a type of kidney inflammation caused by lupus — in adults who are already receiving standard therapy for the condition.

See full Obinutuzumab Injection drug information
Keep checking

Other Drugs & Chirata

Browse every other medication we’ve checked against Chirata — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
86Moderate
0Minor
2,743No known interaction
Moderate

86 interactions

Showing 60 of 86 moderate interactions — see all 86 on the Chirata page.

No interaction 2,743 drugs checked — show the list
Evidence & sources

Chirata References

The 1 references that drive our Chirata monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Sekar, B. C., Mukherjee, B., Chakravarti, R. B., and Mukherjee, S. K. Effect of different fractions of Swertia chirayita on the blood sugar level of albino rats. J.Ethnopharmacol. 1987;21(2):175-181. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Chirata and Obinutuzumab Together: Common Questions

Is it safe to take Chirata with Obinutuzumab?
We do not list a known interaction between Chirata and Obinutuzumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Should I take Chirata and Obinutuzumab at the same time of day?
At least one FDA label for a product containing Obinutuzumab says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Obinutuzumab on its own and move Chirata to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
Are Chirata and Obinutuzumab used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Chirata in each. That is a conversation for your prescriber, especially if Obinutuzumab is being adjusted to a target.
Does Chirata interact with any other medications?
Yes. Chirata has 86 documented drug interactions in our database — Obinutuzumab is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Obinutuzumab and Chirata?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.